Folgen
Giuseppe Nicola Giordano
Giuseppe Nicola Giordano
Sonstige NamenGN Giordano, Giuseppe N. Giordano
Head of Genetic and Molecular Epidemiology (GAME) unit, Lund University, LUDC, Sweden
Bestätigte E-Mail-Adresse bei med.lu.se
Titel
Zitiert von
Zitiert von
Jahr
The impact of changes in different aspects of social capital and material conditions on self-rated health over time: a longitudinal cohort study
GN Giordano, M Lindstrom
Social Science & Medicine 70 (5), 700-710, 2010
2712010
Social capital and self-rated health–a study of temporal (causal) relationships
GN Giordano, J Björk, M Lindström
Social science & medicine 75 (2), 340-348, 2012
1792012
Social capital and change in psychological health over time
GN Giordano, M Lindström
Social Science & Medicine 72 (8), 1219-1227, 2011
1372011
Social capital and health—Purely a question of context?
GN Giordano, H Ohlsson, M Lindström
Health & place 17 (4), 946-953, 2011
1212011
The impact of social capital on changes in smoking behaviour: a longitudinal cohort study
GN Giordano, M Lindström
The European Journal of Public Health 21 (3), 347-354, 2011
952011
The association between cannabis abuse and subsequent schizophrenia: a Swedish national co-relative control study
GN Giordano, H Ohlsson, K Sundquist, J Sundquist, KS Kendler
Psychological medicine 45 (2), 407-414, 2015
942015
The 2008 financial crisis: Changes in social capital and its association with psychological wellbeing in the United Kingdom–A panel study
M Lindström, GN Giordano
Social Science & Medicine 153, 71-80, 2016
862016
Trust and health: testing the reverse causality hypothesis
GN Giordano, M Lindström
J Epidemiol Community Health 70 (1), 10-16, 2016
652016
Chinese citizen satisfaction with government performance during COVID-19
C Wu, Z Shi, R Wilkes, J Wu, Z Gong, N He, Z Xiao, X Zhang, W Lai, ...
Journal of Contemporary China 30 (132), 930-944, 2021
632021
Lifestyle precision medicine: the next generation in type 2 diabetes prevention?
PM Mutie, GN Giordano, PW Franks
BMC medicine 15, 1-11, 2017
632017
Unexpected adverse childhood experiences and subsequent drug use disorder: a Swedish population study (1995–2011)
GN Giordano, H Ohlsson, KS Kendler, K Sundquist, J Sundquist
Addiction 109 (7), 1119-1127, 2014
622014
Replication and cross-validation of type 2 diabetes subtypes based on clinical variables: an IMI-RHAPSODY study
RC Slieker, LA Donnelly, H Fitipaldi, GA Bouland, GN Giordano, ...
Diabetologia 64 (9), 1982-1989, 2021
582021
Predicting and elucidating the etiology of fatty liver disease: A machine learning modeling and validation study in the IMI DIRECT cohorts
N Atabaki-Pasdar, M Ohlsson, A Viñuela, F Frau, H Pomares-Millan, ...
PLoS medicine 17 (6), e1003149, 2020
572020
Four groups of type 2 diabetes contribute to the etiological and clinical heterogeneity in newly diagnosed individuals: An IMI DIRECT study
A Wesolowska-Andersen, CA Brorsson, R Bizzotto, A Mari, A Tura, ...
Cell Reports Medicine 3 (1), 2022
532022
Sharing data for future research'engaging participants' views about data governance beyond the original project: a DIRECT Study
N Shah, V Coathup, H Teare, I Forgie, GN Giordano, TH Hansen, ...
Genetics in Medicine 21 (5), 1131-1138, 2019
512019
An investigation of causal relationships between prediabetes and vascular complications
PM Mutie, H Pomares-Millan, N Atabaki-Pasdar, N Jordan, R Adams, ...
Nature Communications 11 (1), 1-11, 2020
472020
Trust and all-cause mortality: a multilevel study of US General Social Survey data (1978–2010)
GN Giordano, J Mewes, A Miething
J Epidemiol Community Health 73 (1), 50-55, 2019
382019
Testing the association between social capital and health over time: a family-based design
GN Giordano, J Merlo, H Ohlsson, M Rosvall, M Lindström
BMC Public Health 13, 1-9, 2013
382013
Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials
AY Dawed, A Mari, A Brown, TJ McDonald, L Li, S Wang, MG Hong, ...
The Lancet Diabetes & Endocrinology 11 (1), 33-41, 2023
372023
Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: descriptive characteristics of the epidemiological studies within the IMI …
Koivula RW, Forgie I, Kurbasic A, Viñuela A, Heggie A, Giordano GN, et al.
Diabetologia, 1-15, 2019
37*2019
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20